The largest database of trusted experimental protocols
> Chemicals & Drugs > Organic Chemical > Poloxamer 188

Poloxamer 188

Poloxamer 188 is a non-ionic surfactant and block copolymer widely used in pharmaceutical and biomedical applications.
It is composed of polyethylene oxide and polypropylene oxide subunits, and is known for its ability to improve drug solubility, enhance cell membrane permeability, and provide cryoprotective effects.
Poloxamer 188 has been studied for its potential therapeutic applications in areas such as drug delivery, tissue engineering, and nanoparticle formulations.
Researchers can optimize their Poloxamer 188 studies using PubCompare.ai, a leading AI-driven protocol comparison platform that helps identify relevant protocols from literature, pre-prints, and patents, and provides advanced tools to determine the best protocols and products for their research needs.
PubCompare.ai can streamlnie the research process and assist in making informed decisions for Poloxamer 188-related studies.

Most cited protocols related to «Poloxamer 188»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2013
Albuterol Sulfate Amber Drug Combinations Electrostatics Ethanol Excipients High-Performance Liquid Chromatographies Leucine Pharmaceutical Preparations Poloxamer 188 Powder Surfactants
The in-vitro skin permeation of RT from the NEG systems was evaluated using a static Franz diffusion cell [24 (link)]. A Franz diffusion cell is divided into two compartments (donor and receptor compartments) and a sample of shaved, excised dorsal skin from Wistar rats was mounted between these two compartments. The RT-NEG sample was applied to the donor compartment, while the receptor compartment was filled with release medium (PBS, pH 5.5) and the whole assembly was maintained at 37 °C. Aliquots were collected at different time intervals (0, 0.25, 0.5, 1, 2, 3, 4, 6, 8, 10, 12, and 24 h) and replaced by an equal volume of receptor media. The aliquots were analyzed using a UV spectrophotometer (λmax 325 nm) to elucidate the cumulative amount of drug that had permeated the skin by the various time intervals.
In-vitro drug deposition within the skin was evaluated using the same skin samples utilizing the tape-stripping technique [25 (link)]. The skin samples were unclipped from the Franz diffusion cells after 24 h of the permeation study and then washed with PBS. Cellophane tape was used for the tape stripping of skin. The first strip of tape was discarded due to the fact they potentially contained drug that was adhered to the surface of the skin sample. Approximately 10 strips were used in the removal of the entire subcutaneous (SC) layer of skin, in a manner that utilized the maximum area of tape. The treated skin samples and tape used for the stripping procedure were both then chopped and incubated in ethanol to completely extract the RT. Afterward, samples were sonicated for 15 min and then centrifuged at 3000 rpm for 15 min. The extracted samples were analyzed by UV spectroscopy at λmax 325 nm to measure the amount of RT deposited in the skin. This procedure for quantifying the skin permeation was then repeated for the RT-gel (accurately weighed amounts of RT dissolved in the small quantity of propylene glycol and dispersed into placebo gel to obtain RT-gel of strength 1% w/w) and RT creams (accurately weighed amounts of RT in the required quantity of cream base [composed of PEG 4000, PEG 400, lanolin, glyceryl monostearate, and poloxamer 188] to obtain a RT cream at a concentration of 1% w/w) in order to compare the skin permeation of RT with that of the developed NEG systems.
Full text: Click here
Publication 2020
A-A-1 antibiotic Cellophane Cells Diffusion Ethanol glyceryl monostearate Lanolin Pharmaceutical Preparations Placebos Poloxamer 188 polyethylene glycol 400 Propylene Glycol Rats, Wistar Skin Skin Tape Spectrum Analysis Tissue Donors

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2010
Alabaster Buffers HEPES High-Performance Liquid Chromatographies Lipids Pharmaceutical Preparations Poloxamer 188 polyethylene glycol 2000 Polyvinyl Alcohol Sucrose Sulfate, Sodium Dodecyl Sulfates, Inorganic Surface-Active Agents Surfactants Zirconium
The preparation method of chitosan-coated SIM–QRC NPs was statistically optimized by using response surface methodology (RSM) and this strategy helps in identifying the significant variables, best process conditions and to study the interaction between key variables and responses with fewer experiments [35 (link)]. Two independent variables, namely poloxamer 188 (X1) and chitosan concentrations (X2) at five different levels, plus and minus alpha (+1.414 and −1.414: axial points), plus and minus 1 (factorial points) and the center point were optimized for particle size (PS-Y1), entrapment efficacy (EE-Y2) and stability index (SI-Y3). In this experiment, face-centered central composite design (FCCCD) was employed using Design-Expert 12 software (Stat Ease Inc., Minneapolis, MN, USA) to generate 13 experimental runs. The full experimental plans in terms of actual and coded levels of parameters are represented in Table 4. ANOVA was used to establish the statistical validation of the polynomial equations generated. All the responses observed were concurrently fitted to different models. The best fitting experimental model (main, interaction and quadratic) was taken statistically based on a comparison of several statistical parameters like coefficient of variation (CV), multiple correlation coefficient (R2), adjusted R2 (Adju.R2) and predicted R2 (Pred.R2) [36 (link)]. The level of significance was considered at p-values < 0.05. A multiple factorial regression analysis (2FI for particle size and a quadratic model for EE) was carried out to measure the response (Yi) in each trial.
Yi(2FI)=b0+b1X1+b2X2+b3X3+b4X1X2+b5X1X3+b6X2X3
Yi(Quadratic)=b0+b1X1+b2X2+b3X3+b4X1X2+b5X1X3+b6X2X3+b7X12+b8X22+b9X32
where Yi is the dependent variable, b0 is the arithmetic mean response of all trials, bi is the estimated coefficient for factors, X1, X2, and X3 (the main effects), which are the average values of the changing factors one at a time. X1X2 and X1X3 and X2X3 represent the interaction terms and X12 , X22 and X32 represent the polynomial terms.
Full text: Click here
Publication 2020
Chitosan Face Infantile Neuroaxonal Dystrophy neuro-oncological ventral antigen 2, human Poloxamer 188 Vitelliform Macular Dystrophy
Components of the DMSO-free freezing solutions in this investigation included sucrose (Sigma-Aldrich), glycerol (Humco), L-isoleucine (Sigma-Aldrich), human serum albumin (Albutein, Grifols), poloxamer 188 (P188, Spectrum Chemical), MEM non-essential amino acids (NEAA, Sigma-Aldrich) and Hank's Balanced Saline Solution with Ca2+, Mg2+, and glucose (HBSS, Lonza). The final working concentrations of the DMSO-free CPA molecules—sucrose, glycerol, isoleucine, and albumin—were varied to optimize the composition of the freezing solution. A basal buffer composed of P188 at a non-micelle forming concentration, NEAA and HBSS were kept constant for all DMSO-free freezing solutions studied. DMSO (Sigma-Aldrich) was used as a control at an optimized concentration of 7.5%, and HBSS was used as its basal buffer. The DMSO-free compositions discussed in this article are covered by issued Patent #10,314,302 and patent application #US2019/0269124, owned by Regents of the University of Minnesota. The solutions used in this article can be acquired directly from the authors for replication of the studies.
Full text: Click here
Publication 2020
Albumins Amino Acids, Essential Buffers DNA Replication Glucose Glycerin Hemoglobin, Sickle Isoleucine Micelles Poloxamer 188 Saline Solution Serum Albumin, Human Sucrose Sulfoxide, Dimethyl

Most recents protocols related to «Poloxamer 188»

Example 1

TABLE 1
IngredientsQty/vial
Melphalan50mg
Poloxamer 1885mg
Polyethylene glycol (PEG)4ml
Ethanol6ml
0.1N HClQS

Melphalan was added to a manufacturing vessel containing a mixture of solvents polyethylene glycol (PEG) and ethanol. Polaxomer 188 was added to obtain a clear solution. pH was adjusted to 3.5-5.5 using 0.1N HCl. Volume was made up using a mixture of PEG and ethanol. The obtained solution was filtered and filled in vials followed by capping and sealing. The melphalan formulation was tested for stability at 25° C./60% RH for a period of 43 days. Stability data is summarized in Table 1A.

TABLE 1A
Stability at Day 43Day 43
Purity90.41
Maximum Individual Impurity3.3
Total Impurities9.59

Full text: Click here
Patent 2024
Blood Vessel Ethanol Melphalan Poloxamer 188 Polyethylene Glycols Solvents
Not available on PMC !

Example 3

The method of any one or more of Examples 1 through 2, wherein the humidity tolerant adhesive material comprises a blend of poloxamers.

Example 4

The method of Example 3, wherein the poloxamers are selected from the group consisting of: poloxamer 188; Synperonic® PE/P84; poloxamer 124; poloxamer 407; and combinations thereof.

Full text: Click here
Patent 2024
Humidity Poloxamer Poloxamer 188 Poloxamer 407 Poloxamers

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
A-A-1 antibiotic Buffers Cells Cloning Vectors Embryo Filtration Genome Homo sapiens Kidney Large T-Antigen Oligonucleotide Primers Open Reading Frames Pharmaceutical Preparations Physical Examination Poloxamer 188 Safety Simian virus 40 Sodium Chloride Sterility, Reproductive Technique, Dilution Transfection
The APT-IE formulation was designed and optimized using the central composite design response surface methodology (CCD-RSM). According to the results of single-factor experiments, three independent variables were designed of the proportion of sodium oleate (X1, 0.05–0.7%), poloxamer 188 (X2, 0–1.2%), and oil (X3, 8–18%) used. The aim of this study was to reduce the size of APT-IE. Due to smaller emulsion droplets undergo reduced Brownian movement, the emulsion is more stable. In addition, the drug absorption can be enhanced with smaller particle sizes and thus realized the greater improvements of bioavailability. The 20 runs designed by CCD were presented in Table 1.
Full text: Click here
Publication 2023
Emulsions Movement osteum Pharmaceutical Preparations Poloxamer 188
Aprepitant (APT, purity ≥ 98.5%) was purchased from Zhongshan Yiantai Pharma Co. Ltd. (Guangzhou, China). Egg yolk lecithin and sodium oleate were purchased from Shanghai A.V.T. Pharma Co. Ltd. (Shanghai, China). Poloxamer 188 (F68), sucrose and medium-chain triglyceride (MCT) were purchased from Xi’an Tianzheng Medicinal Materials Co. Ltd. (Zhejiang, China). Ethanol was purchased from Shandong Long Yu Quan Pharmaceutical Excipients Co. Ltd. (Shandong, China). All chemicals and reagents were of analytical or HPLC grade.
Full text: Click here
Publication 2023
Aprepitant Ethanol Excipients High-Performance Liquid Chromatographies Lecithin osteum Poloxamer 188 Sucrose Triglycerides Yolks, Egg

Top products related to «Poloxamer 188»

Sourced in United States, Germany, India, China, France, Brazil
Poloxamer 188 is a nonionic, water-soluble surfactant commonly used in pharmaceutical and biomedical applications. It is a triblock copolymer composed of a central hydrophobic polypropylene oxide (PPO) block flanked by two hydrophilic polyethylene oxide (PEO) blocks. Poloxamer 188 exhibits emulsifying, wetting, and stabilizing properties, making it useful as a dispersing agent, solubilizer, and excipient in various formulations.
Sourced in Germany, India, China, United States, Spain
Poloxamer 188 is a nonionic, water-soluble block copolymer. It is commonly used as a surfactant, emulsifier, and dispersing agent in various laboratory and industrial applications.
Sourced in United States, Germany, United Kingdom, India, Italy, France, Sao Tome and Principe, Spain, Poland, China, Belgium, Brazil, Switzerland, Canada, Australia, Macao, Ireland, Chile, Pakistan, Japan, Denmark, Malaysia, Indonesia, Israel, Saudi Arabia, Thailand, Bangladesh, Croatia, Mexico, Portugal, Austria, Puerto Rico, Czechia
Tween 80 is a non-ionic surfactant and emulsifier. It is a viscous, yellow liquid that is commonly used in laboratory settings to solubilize and stabilize various compounds and formulations.
Sourced in France, United States, India, Spain, Germany
Precirol® ATO 5 is a lipid excipient used in the formulation of pharmaceutical and cosmetic products. It is a glycerol palmitostearate with a melting point range of 53-57°C. Precirol® ATO 5 is commonly used as a lubricant, binder, and release-modulating agent in solid dosage forms.
Sourced in France, United States, India, Germany, Poland
Compritol® 888 ATO is a glyceryl behenate-based lipid excipient used in the development of pharmaceutical and cosmetic formulations. It is a white, waxy solid material with a melting point range of 69-74°C. Compritol® 888 ATO is commonly used as a lubricant, glidant, and binder in solid dosage forms.
Sourced in Germany, United States, Italy, India, China, United Kingdom, France, Poland, Spain, Switzerland, Australia, Canada, Brazil, Sao Tome and Principe, Ireland, Belgium, Macao, Japan, Singapore, Mexico, Austria, Czechia, Bulgaria, Hungary, Egypt, Denmark, Chile, Malaysia, Israel, Croatia, Portugal, New Zealand, Romania, Norway, Sweden, Indonesia
Acetonitrile is a colorless, volatile, flammable liquid. It is a commonly used solvent in various analytical and chemical applications, including liquid chromatography, gas chromatography, and other laboratory procedures. Acetonitrile is known for its high polarity and ability to dissolve a wide range of organic compounds.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in Germany, United States, India, United Kingdom
Poloxamer 407 is a non-ionic, water-soluble triblock copolymer. It is composed of a central hydrophobic block of polypropylene oxide (PPO) flanked by two hydrophilic blocks of polyethylene oxide (PEO). Poloxamer 407 is typically used in the formulation of various lab equipment and materials due to its unique physicochemical properties.
Sourced in France, India, United States, Germany, Canada, China
Labrasol is a non-ionic surfactant used in various pharmaceutical and cosmetic applications. It is a polyoxyethylene glycerol fatty acid ester that acts as a solubilizer, emulsifier, and wetting agent. Labrasol is designed to improve the solubility and bioavailability of active ingredients in formulations.
Sourced in United States, Germany, United Kingdom, China, Italy, Sao Tome and Principe, France, Macao, India, Canada, Switzerland, Japan, Australia, Spain, Poland, Belgium, Brazil, Czechia, Portugal, Austria, Denmark, Israel, Sweden, Ireland, Hungary, Mexico, Netherlands, Singapore, Indonesia, Slovakia, Cameroon, Norway, Thailand, Chile, Finland, Malaysia, Latvia, New Zealand, Hong Kong, Pakistan, Uruguay, Bangladesh
DMSO is a versatile organic solvent commonly used in laboratory settings. It has a high boiling point, low viscosity, and the ability to dissolve a wide range of polar and non-polar compounds. DMSO's core function is as a solvent, allowing for the effective dissolution and handling of various chemical substances during research and experimentation.

More about "Poloxamer 188"

Poloxamer 188, also known as Pluronic F-68, is a versatile non-ionic surfactant and block copolymer widely used in pharmaceutical and biomedical applications.
This polymeric compound is composed of polyethylene oxide (PEO) and polypropylene oxide (PPO) subunits, which give it unique properties that make it valuable in various fields.
One of the key features of Poloxamer 188 is its ability to improve drug solubility, a crucial factor in the development of effective pharmaceutical formulations.
By enhancing the solubility of poorly soluble drugs, Poloxamer 188 can improve their bioavailability and therapeutic efficacy.
This surfactant has also been studied for its potential to enhance cell membrane permeability, allowing for improved drug delivery and tissue penetration.
Researchers often compare Poloxamer 188 to other excipients, such as Tween 80, Precirol® ATO 5, and Compritol® 888 ATO, to determine the most suitable formulation for their specific needs.
Additionally, Poloxamer 188 has been investigated for its cryoprotective effects, making it useful in tissue engineering and nanoparticle formulations.
To optimize their Poloxamer 188 studies, researchers can utilize PubCompare.ai, a leading AI-driven protocol comparison platform.
This tool helps identify relevant protocols from literature, pre-prints, and patents, and provides advanced AI-powered tools to determine the best protocols and products for their research needs.
By streamlining the research process and assisting in informed decision-making, PubCompare.ai can enhance the efficiency and effectiveness of Poloxamer 188-related studies.
The versatility of Poloxamer 188, combined with the power of PubCompare.ai, makes it a valuable tool for researchers working in the fields of drug delivery, tissue engineering, nanoparticle formulations, and beyond.
Whether you're exploring the solubility-enhancing properties of Poloxamer 188 or investigating its cryoprotective effects, PubCompare.ai can help you navigate the literature and optimize your research workflow.